Eli Lilly and Company (LLY)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
Pre-Market:
| Previous Close | 732.20 |
| Open | 725.00 |
| Bid | 728.20 x 1000 |
| Ask | 729.31 x 1100 |
| Day's Range | 718.30 - 727.99 |
| 52 Week Range | 392.26 - 800.78 |
| Volume | |
| Avg. Volume | 3,066,637 |
| Market Cap | 689.182B |
| Beta (5Y Monthly) | 0.37 |
| PE Ratio (TTM) | 124.98 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | 5.20 (0.72%) |
| Ex-Dividend Date | Feb 14, 2024 |
| 1y Target Est | N/A |
- Investor's Business Daily
Is Eli Lilly Stock A Buy After Weight-Loss Drug Succeeds In Sleep Apnea Patients?
Lilly is soon planning to ask global regulators to approve tirzepatide for sleep apnea treatment. Is Eli Lilly stock a buy?
- Insider Monkey
20 Fastest Growing Health Tech Companies in the World
In this article, we will be taking a look at the 20 fastest growing health tech companies in the world. If you do not want to learn about the trends in digital health market, head straight to the 5 Fastest Growing Health tech Companies in the World. Explosive Growth and Key Trends in the Digital […]
- Zacks
Gear Up for Lilly (LLY) Q1 Earnings: Wall Street Estimates for Key Metrics
Besides Wall Street's top -and-bottom-line estimates for Lilly (LLY), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended March 2024.
© 2024 Yahoo. All rights reserved.